Strides Consumer launches joint pain relief, nicotine replacement products

The two products are being produced at a third-party unit owned by Strides Pharma group; firm is currently building a distributor network across 50 cities in the south

Strides Consumer Private Limited (SCPL), a new entrant in the Rs 27,000-crore Indian consumer healthcare product market, on Wednesday formally announced the launch of two maiden products -- Nixit for oral nicotine replacement therapy (NRT) and Jointflex cream for joint pain relief and management in the southern market.

Strides Consumer is owned by InvAscent-backed Indian Life Sciences Fund and Strides Pharma Science Ltd (formerly Strides Shasun) with 74 per cent and 26 per cent shareholding in the company, respectively. It aims to offer high quality, differentiated products in consumer healthcare, based on best of global products with Indian customisation.

Stating